Manufacturer record
Medipol Pharmaceuticals India Pvt. Ltd. 1199/3: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Medipol Pharmaceuticals India Pvt. Ltd. 1199/3 (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Medipol Pharmaceuticals India Pvt. Ltd. 1199/3 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen Oral Suspension BP 100 mg/5ml | IBS-022Mfg 2024-07 · Exp 2026-06 | The sample does not conform to claim as per BP 2024 in respect to the Assay of IbuprofenAssay | DTL Baddi Distt. SolanState lab | May 2025 |
| Ferrous Sulphate & Folic Acid Syrup IP | FSF-158Mfg 2024-10 · Exp 2026-09 | The sample does not conform to claim as per IP 2022 in respect to the Test of Free Ferric Compounds & Assay of Folic AcidAssay | DTL Baddi Distt. SolanState lab | May 2025 |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P. | TMNL-018Mfg 2019-01 · Exp 2020-12 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P. | TMNL-018Mfg 2019-01 · Exp 2020-12 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
| Levocetirizine & Montelukast Tablets I.P. | TMNL-008Mfg 2018-12 · Exp 2020-11 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.